Formulation characterisation and in-vitro evaluation of liposomal drug delivery system of sitagliptin for prolonged release

Authors

  • B. Narasimha Rao P. Rami Reddy Memorial College of Pharmacy, Kadapa, Andhra Pradesh. Author
  • V. Dharsana P. Rami Reddy Memorial College of Pharmacy, Kadapa, Andhra Pradesh. Author
  • S. Nelson Kumar P. Rami Reddy Memorial College of Pharmacy, Kadapa, Andhra Pradesh. Author
  • P. Gowtham Kumar Reddy P. Rami Reddy Memorial College of Pharmacy, Kadapa, Andhra Pradesh. Author

DOI:

https://doi.org/10.33974/6bvbew27

Keywords:

Physical dispersion, Ether injection, soya lecithin, cholesterol, Sitagliptin

Abstract

Sitagliptin is widely used for the treatment of diabetes; the intention of the present study was to formulate Sitagliptin liposomes for a Prolonged drug delivery system. It have the advantages of dose reduction, less dosing frequency, minimize the side effect, prolong the action of drug and thus achieve better patient compliance. The liposomes were prepared by physical dispersion and ether injection method. Soya lecithin and cholesterol were used for encapsulating the drug, it facilitates to release the medicaments in sustained manner. Chloroform, ether and methanol were used as a solvent. Phosphate buffer pH 6.8 was used as a hydration medium for loading the drug. The final liposome was evaluated in various quality parameters of drug entrapment efficiency, morphological analysis, particle size analysis, in-vitro drug release studies and stability studies. In the two methods of Sitagliptin liposome formulation the ether injection method showed prolonged action when compared to physical dispersion method. In the parameters of drug entrapment and stability physical dispersion method was shows better results.

Downloads

Download data is not yet available.

References

Charman WN, Chan HK, Finnin BC, Charman SA. Drug delivery: A key factor in realising the full therapeutic potential of drugs. Drug Dev Res. 1999;46:316–27.

NazilaSalamat-Miller, MontakarnChittchang, Thomas P. Johnston. The use of mucoadhesive polymers in buccal drug delivery. Advanced Drug Delivery Reviews. 2005; 57: 1666– 1691.

Oliver A. Scholz, Andy Wolff, Axel Schumacher, Libero. Giannola, GiuseppinaCampisi, Tomasz Ciach, Thomas Velten. Drug delivery from the oral cavity: focus on a novel mechatronic delivery device. Drug Discovery Today. March 2008; 13: 247-253.

Garidel, P., Johann, C. & Blume, a. Thermodynamics of lipid organization and domain formation in phospholipid bilayers. J. Liposome Res., 2000 10, 131‐158.

Mashaghi et al. Journal of Chemical Physics 136, 114709 (2012)

W.W. Christie, Phosphatidylethanolamine and related lipids; lipidlibrary.aocs.org.

Kant seshim, Kumar satinder, Prashar Bharat, A complete review on Liposomes;IRJP 2012, 3(7).

Priyanka R Kulkarni*, Jaydeep D Yadav, Kumar A Vaidya; Liposomes: A Novel Drug Delivery System, Int J Curr Pharm Res, Vol 3, Issue 2, 1018

Amarnath Sharma *, Uma S. Sharma, Liposomes in drug delivery: progress and limitations, International Journal of Pharmaceutics 154 (1997) 123 140

J.S. Dua , Prof. A. C. Rana, Dr. A. K. Bhandari; Liposome: Methods Of Preparation And Applications

Liposomes, second edition; Vladimir.P Torchilin and Volkmar Weissig, Practical approach, 2003.

Vladimir P. Torchilin Recent Advances With Liposomes As Pharmaceutical Carriers; Nature Reviews | Drug Discovery, Volume 4, Feb 2005 | 145

D.D. LASIC; Applications of Liposomes, Liposome Technology, Inc. Handbook of Biological Physics, Volume 1.

Dan D. Lasic, Novel applications of liposomes; Tibtech July 1998 (Vol 16)

Pasquier. F Diabetes and cognitive impairment: how to evaluate the cognitive status? Diabetes and metabolism. 2010 Oct 36 supp 3: S 100-5

U.S. Department Of Health and Human Services National Institutes of Health NIH Publication No. 09–4642 October

John W Park, Liposome-based drug delivery in breast cancer treatment; Breast Cancer Res 2002, 4:95-99

Vibhuti Gupta, Roohi Gupta, , Rahul Grover, , Rajat Khanna, , Vijeta Jangra, , and Aditya Mittal, Delivery of Molecules to Cancer Cells Using Liposomes from Bacterial Cultures; Journal of Nanoscience and Nanotechnology Vol. 8, 1–6, 2008

Amol B. Pitrubhakta*, Anilkumar J. Shinde, Namdeo R. Jadhav; Design, Development and Characterization of PEGylated Liposomes of Gemcitabine Hydrochloride, Der Pharmacia Lettre, 2012, 4 (1):314-329.

Kathryn A. Melzak , Shirley A. Melzak, Electra Gizeli and José L. Toca-Herrera; Cholesterol Organization in Phosphatidylcholine Liposomes: A Surface Plasmon Resonance Study. Materials 2012, 5, 2306-2325

Oula Penate Medina, Merja Haikola, Marja Tahtinen, Ilkka Simpura, Sami Kaukinen; Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands. Journal of Drug Delivery Volume 2011

Lloyd B. Jeffs, Lorne R. Palmer, Ellen G. Ambegia, Cory Giesbrecht; A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA. Pharmaceutical Research, Vol. 22, No. 3, March 2005

Zimmermann, and David Fleisher; Liposomal Formulations of Inflammatory Bowel Disease Drugs: Local versus Systemic Drug Delivery in a Rat Model. Pharmaceutical Research, Vol. 22, No. 8, August 2005

Published

30-06-2024

Issue

Section

Research Article

Categories

How to Cite

Formulation characterisation and in-vitro evaluation of liposomal drug delivery system of sitagliptin for prolonged release. (2024). International Journal of Research in Pharmaceutical Sciences and Technology, 4(3). https://doi.org/10.33974/6bvbew27

Similar Articles

1-10 of 14

You may also start an advanced similarity search for this article.